That the HIV pandemic has increased TB prevalence globally, but its impact has been highest in developing countries in Africa, Asia, and Latin America [8,9]. Regions where doctors are confronted by drug-resistant tuberculosis provide sufficient evidence of the difficulty of treating both diseases [10]. Factors that contribute to the spread of tuberculosis in the U.S. and elsewhere include the incr
In part, the evolutionary selection of MBL mutant haplotypes that encode low or intermediate MBL serum levels in the majority of humans.Supporting InformationFigure S1 RhMBL enhances HIV-EBOV GP infection in a calcium-dependent manner. We preincubated HIVEBOV-GP virion-like particles with rhMBL in 5 MBL-deficient serum and Veronal-buffered saline with or without calcium supplementation. *, ** and
On of fetal calf or fetal bovine serum typically used for EBOV infectivity assays [17,18,44,45,67]. Given that C4 gene copy number variations may lead to a proportionate reduction ofLectin-Dependent Enhancement of Ebola Virusesiological doses of MBL products or blood products with high MBL concentrations to individuals in the setting of infectious diseases and relative hypocomplementemia may be de
On of fetal calf or fetal bovine serum typically used for EBOV infectivity assays [17,18,44,45,67]. Given that C4 gene copy number variations may lead to a proportionate reduction ofLectin-Dependent Enhancement of Ebola Virusesiological doses of MBL products or blood products with high MBL concentrations to individuals in the setting of infectious diseases and relative hypocomplementemia may be de
Exposed to autoradiography film. High-mannose moieties were preserved only in untreated virus confirming that PNGase F and endo H effectively cleaved high-mannose residues on GPs of HIV-EBOV virion-like particles. (EPS) Figure S4 Thermolysin treatment of HIV-EBOV GP abrogates enhancement of infection by rhMBL in a thermolysin-concentration dependent manner. We preincubated HIV-EBOV GP virion-like
On of fetal calf or fetal bovine serum typically used for EBOV infectivity assays [17,18,44,45,67]. Given that C4 gene copy number variations may lead to a proportionate reduction ofLectin-Dependent Enhancement of Ebola Virusesiological doses of MBL products or blood products with high MBL concentrations to individuals in the setting of infectious diseases and relative hypocomplementemia may be de
In part, the evolutionary selection of MBL mutant haplotypes that encode low or intermediate MBL serum levels in the majority of humans.Supporting InformationFigure S1 RhMBL enhances HIV-EBOV GP infection in a calcium-dependent manner. We preincubated HIVEBOV-GP virion-like particles with rhMBL in 5 MBL-deficient serum and Veronal-buffered saline with or without calcium supplementation. *, ** and
Infections using high level rhMBL (10 mg/ml) in 5 serum (i.e. diluted 20-fold). However, such a high concentration of rhMBL is considered supraphysiological if adjusted for the 20-fold dilution factor of serum. Although human MBL is produced primarily in the liver, extrahepatic MBL synthesis has been found in the gastrointestinal tract, middle ear fluid, and nasopharyngeal secretions. It is possi